Guidance - Spark Newswire

2 minute read

MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies

Today, 10:17 PM

Clinical-stage biopharma company Mind Medicine (MindMed), Inc. (NASDAQ: MNMD) shared its financial results for the full year ended Dec. 31, 2022. Numbers show solid stability:

MNMD

1 minute read

Embraer Shares Gain After Q4 Results, Aircraft Deliveries Increase By 12.7% In FY22

By Akanksha Bakshi

Today, 10:17 PM

Embraer SA (NYSE:ERJ) reported fourth-quarter FY22 revenue of $1.992 billion, an increase of 53% year-over-year, marginally beating the consensus of…

ERJ

1 minute read

Why JinkoSolar Shares Are Sliding Today

By Akanksha Bakshi

Today, 10:17 PM

JinkoSolar Holding Co., Ltd (NYSE:JKS) reported a fourth-quarter FY22 revenue growth of 85.5% year-on-year to $4.41 billion, beating the consensus of…

JKS

1 minute read

Oracle, Buckle And 3 Stocks To Watch Heading Into Friday

By Lisa Levin

Today, 10:17 PM

With US futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

BKE

1 minute read

Oracle Says Expects Q4 Total Cloud Growth Excluding Cerner Of 30% In Constant Currency

By Michael Horton

Today, 10:17 PM

-Reuters

ORCL

1 minute read

Oracle Says Expect To Continue Winning Big Cloud Deals That Are Subscription Driven Vs License Driven

By Michael Horton

Today, 10:17 PM

-Reuters

ORCL

1 minute read

Campbell Soup Gets Price Target Bumps By Analysts After Strong Q2 Results

By Lisa Levin

Today, 10:17 PM

Campbell Soup Co (NYSE: CPB) reported better-than-expected Q2 results and raised FY23 guidance. Campbell reported quarterly sales growth of 12% year-on-year to $2.48 billion, beating the consensus of $2.44 billion. Adjusted EPS of $0.80 beat the analyst consensus of $0.74.

CPB

1 minute read

General Electric Stock Is Rising: What’s Driving The Action?

By Adam Eckert

Today, 10:17 PM

General Electric Co (NYSE: GE) shares are trading higher Thursday after the company updated guidance at its annual investor conference.

1 minute read

ANI Pharmaceuticals Sees FY23 Adjusted EPS of $2.09-$2.59 Vs. Consensus Of $2.62; Forecasts Revenues Of $360M-$385M Vs. $352.49M Estimate

By Benzinga Newsdesk

Today, 10:17 PM

2023 Cortrophin specific revenue guidance is between $80.0 million to $90.0 million, representing 92% to 116% growth as compared to $41.7 million recognized in

ANIP

1 minute read

Asana CEO Plans To Purchase Up To 30M Stock Under Trading Plan, Shares Soar

By Anusuya Lahiri

Today, 10:17 PM

On March 8, 2023, Asana, Inc (NYSE:ASAN) Chair and CEO Dustin Moskovitz shared plans to purchase up to 30 million…

ASAN